Delivery Order SPE2DX22D0049-SPE2D825FA3JA

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $10K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. government has awarded a Delivery Order contract worth $26,939.38 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (Defense agency), and has an ultimate completion date of December 3, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
The U.S. government awarded a delivery order worth $10,023.75 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. This contract, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs,...
The U.S. government awarded a delivery order contract valued at $10,619.52 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of October 22, 2024, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. It is a firm fixed-price contract for the delivery of various pharmaceutical products and medical supplies, including specialty medications, generic drugs, vaccines, syringes,...
The U.S. government has awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,995.94, was issued by the Defense Logistics Agency (DLA) Troop Support Medical and is a child order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999. This IDC serves as a primary vehicle for the company to provide a comprehensive range of...
The U.S. government has awarded a Delivery Order contract worth $12,960.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other government agencies. This contract is part of a larger Indefinite Delivery Contract (IDC) between...
The U.S. Defense Logistics Agency (DLA) awarded a $7,022.60 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide pharmaceutical products and medical supplies. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to the Department of...
The U.S. government has awarded a Delivery Order contract worth $1,164.26 to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of April 23, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to...
The U.S. government awarded a Delivery Order contract valued at $4,070.88 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and covers the supply of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a Period of Performance through January...
The U.S. government has awarded a Delivery Order contract valued at $35,160.24 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is being issued by the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense's (DoD) medical treatment programs and facilities worldwide. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 through December 2025 with...
The U.S. government awarded a Delivery Order contract worth $146,899.64 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a completion date of October 22, 2024, is a Firm Fixed Price arrangement with the Defense Logistics Agency (DLA) Troop Support Medical, an agency within the Department of Defense. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DX22D0049
    Indefinite Delivery Contract
  • SPE2DX22D0049-SPE2D825FA3JA
    Delivery Order

The U.S. government has awarded a Delivery Order contract valued at $10,396.92 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense.

This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 5/4/25, 12:51 AM